Corrected-PepGen Shares Fall 18.8% Premarket on Receiving Clinical Hold Notice From US FDA for Mid-Stage Muscle Disorder Study (Adds Dropped Word "Premarket")

THOMSON REUTERS
16 Dec 2024

Corrected-PepGen Shares Fall 18.8% Premarket on Receiving Clinical Hold Notice From US FDA for Mid-Stage Muscle Disorder Study (Adds Dropped Word "Premarket")

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10